Why the study?
Does ranolazine improve coronary flow reserve in patients with angina and myocardial ischemia but no obstructive CAD?
Does ranolazine improve coronary flow reserve in patients with angina and myocardial ischemia but no obstructive CAD?
Ranolazine significantly improves coronary flow reserve in patients with angina and myocardial ischemia without obstructive CAD, suggesting a benefit for microvascular dysfunction.
No takes yet. Share an insight, caveat, or question.
Supports ranolazine for microvascular angina; extends randomized evidence of CFR benefit in nonobstructive CAD.
Tagliamonte et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: